Second Quarter Revenue Increased 75% YoY and 54% Sequentially to $3.4 Million
New Distribution Agreements for Complementary Products and Product Launches Enhance Portfolio
ONTARIO, Calif., Aug. 16, 2024 /PRNewswire/ — Nature’s Miracle Holding Inc. (NASDAQ: NMHI) ("Nature’s Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, today reported its financial and operational update for the second quarter ended June 30, 2024.
Second Quarter 2024 and Subsequent Business Updates
Revenue of $3.4 million, a 75% increase from the same period in 2023, and a 54% increase compared to the first quarter of 2024. Gross margin improved 800 basis points to 13.3% from the same period in 2023. Launched and completed first shipment of Efinity brand Smart Dehumidifier product. Developed a strong pipeline of grow light orders within the energy rebate market with total grow light purchase orders of $5 million in July.
Management Commentary
James Li, Chairman and Chief Executive Officer of Nature’s Miracle, commented, "During the first full quarter as a public company, Nature’s Miracle recognized significant revenue growth, strong new order trends for our existing products and diversification of our portfolio with the launch of new products and new distribution partners. In the second quarter, we achieved revenue growth of 75% from the prior year period, which was driven by strong demand from the energy rebate market for LED grow light products and increases in our marketing team and efforts. Our 800-basis point expansion of gross margin was the result of higher margins realized through the Company’s Efinity brand products, favorable pricing trends from Asian manufacturers and incentive costs to the Company for operating in the energy rebate market. Taken together, we are rapidly growing our footprint across the North American market with our vertically integrated approach of products and solutions for the CEA market."
"We are pleased with our progress through the first half of 2024, and at this early stage of development as a public company. Our strategic focus is on continuing to build a foundation of existing, new and licensed products as catalysts for revenue growth in the second half of 2024 and beyond. The record purchase orders received in July are an indication that Nature’s Miracle is well positioned in the market and with our effective sales and marketing channels, we will seek to further capitalize on this momentum. A defining component of our sales and marketing efforts focuses on reinforcing our distinct position as a fully integrated provider of comprehensive vertical farms," concluded Mr. Li.
Second Quarter 2024 Financial Summary
For the second quarter of 2024, revenue totaled $3.4 million, increasing 75% from $1.9 million in the prior year period. The increase was primarily attributable to an increase in demand of our Efinity LED light products from the energy rebate market and the increases in our sales force as catalyst for this growth.
Gross profit for the second quarter of 2024 totaled $0.5 million or 13.3% of revenue, as compared to $0.1 million or 5.2% of revenue in the prior year period. The increase in gross profit as a percentage of revenue was primarily attributable to the higher margin component of our Efinity brand products and the finance structure of the energy rebate market.
Selling, general and administrative expenses increased to $1.5 million compared to $0.5 million in the prior year period. The increase was primarily due to public company costs, higher spend on staffing related, legal, accounting and other professional fees as well as stock compensation charges.
Net loss for the second quarter of 2024 totaled $1.8 million, or $(0.07) per share, and net loss of $0.4 million, or $(0.02) per share in the prior year period.
Cash and cash equivalents totaled $30,532 at June 30, 2024, compared to $221,760 at December 31, 2023. Subsequent to quarter end, on July 29, 2024, the company closed a public offering for aggregate gross proceeds of $1.2 million.
About Nature’s Miracle Holding Inc.
Nature’s Miracle (NASDAQ: NMHI) is a growing agriculture technology company providing equipment and services to growers in the Controlled Environment Agriculture ("CEA") industry which also includes vertical farming in North America. Nature’s Miracle offers hardware to design, build and operate various indoor growing settings including greenhouse and indoor-growing spaces. Nature’s Miracle, through its two wholly-owned subsidiaries Visiontech Group, Inc. and Hydroman, Inc., provides grow lights as well as other hydroponic products to hundreds of indoor growers in North America. For more information visit www.Nature-Miracle.com.
Forward-Looking Statements
The information in this press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "intends," "may," "will," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature’s Miracle’s joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature’s Miracle’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature’s Miracle’s ability to develop and launch new products and services; Nature’s Miracle’s ability to successfully and efficiently integrate future expansion plans and opportunities; Nature’s Miracle’s ability to grow its business in a cost-effective manner; Nature’s Miracle’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature’s Miracle’s business model; developments and projections relating to Nature’s Miracle’s competitors and industry; and Nature’s Miracle’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; the effects of the coronavirus (COVID-19) and any future outbreaks on Nature’s Miracle’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature’s Miracle’s operates; the risk that Nature’s Miracle’s and its current and future collaborators are unable to successfully develop and commercialize Nature’s Miracle’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature’s Miracle’s is unable to secure or protect its intellectual property; the possibility that Nature’s Miracle’s may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature’s Miracle’s filings from time to time with the SEC.
Contacts
George Yutuc
Chief Financial Officer
[email protected]
MZ North America
Shannon Devine / Rory Rumore
Main: 203-741-8811
[email protected]
NATURE’S MIRACLE HOLDING INC., SUBSIDIARIES AND VIE
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
For the Three Months Ended
For the Three Months Ended
For the Six Months Ended
For the Six Months Ended
June 30,
June 30,
June 30,
June 30,
2024
2023
2024
2023
(Unaudited)
(Unaudited)
(Unaudited)
(Unaudited)
REVENUE
$
3,404,967
$
1,943,528
$
5,609,687
$
4,910,200
COST OF REVENUE
2,952,747
1,843,257
4,845,150
4,512,669
GROSS PROFIT
452,220
100,271
764,537
397,531
OPERATING EXPENSES:
Selling, general and administrative
1,540,983
458,037
2,684,120
1,015,046
Stock compensation expenses
195,908
–
367,805
–
Total operating expenses
1,736,891
458,037
3,051,925
1,015,046
LOSS FROM OPERATIONS
(1,284,671)
(357,766)
(2,287,388)
(617,515)
OTHER EXPENSES
Interest (expense) income, net
(486,586)
38,890
(788,975)
(360,020)
Non cash finance expense
–
–
(1,000,000)
–
Loss on loan extinguishment
–
(233,450)
–
(233,450)
Other expenses
3,738
6,716
3,738
6,346
Total other expense, net
(482,848)
(187,844)
(1,785,237)
(587,124)
LOSS BEFORE INCOME TAXES
(1,767,519)
(545,610)
(4,072,625)
(1,204,639)
PROVISION FOR (BENEFIT OF) INCOME TAXES
800
(139,040)
2,500
(230,690)
NET LOSS
$
(1,768,319)
$
(406,570)
$
(4,075,125)
$
(973,949)
OTHER COMPREHENSIVE LOSS
Foreign currency translation adjustment
(83)
(65)
(33)
791
COMPREHENSIVE LOSS
$
(1,768,402)
$
(406,635)
$
(4,075,158)
$
(973,158)
WEIGHTED AVERAGE NUMBER OF COMMON STOCK*
Basic and diluted
26,458,515
22,272,478
24,793,466
22,272,478
LOSS PER SHARE
Basic and diluted
$
(0.07)
$
(0.02)
$
(0.16)
$
(0.04)
UNAUDITED CONDENSED BALANCE SHEET
As of June 30,
As of Dec 31,
2024
2023
(Unaudited)
ASSETS
CURRENT ASSETS
Cash and cash equivalent
$
30,532
$
221,760
Accounts receivable, net
2,053,678
1,236,248
Accounts receivable – related parties, net
717,835
305,669
Inventories, net
4,169,333
5,046,084
Prepayments and other current assets
347,465
139,734
Loans receivable – related parties
–
460,000
Total Current Assets
7,318,843
7,409,495
NON-CURRENT ASSETS
Security deposit
27,633
47,633
Right-of-use assets, net
578,179
503,089
Cost method investment
1,000,000
1,000,000
Property and equipment, net
4,326,552
4,406,272
Deferred offering costs
–
833,932
Total Assets
$
13,251,207
$
14,200,421
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Short-term loans
$
2,928,183
$
509,443
Short-term loans – related parties
908,255
783,255
Current portion of long-term debts
284,493
268,805
Accounts payable
8,875,916
8,034,044
Accounts payable – related parties
2,713,074
2,758,074
Other payables and accrued liabilities
3,385,079
1,351,951
Other payables – related parties
292,157
257,954
Operating lease liabilities – current
460,311
359,459
Tax accrual
452,725
340,628
Deferred income – Contract liabilities
64,069
118,909
Total Current Liabilities
20,364,262
14,782,522
NON-CURRENT LIABILITIES
Long-term debts, net of current portion
5,833,562
5,979,939
Operating lease liabilities, net of current portion
184,147
157,897
Total Non-Current Liabilities
6,017,709
6,137,836
Total Liabilities
26,381,971
20,920,358
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ DEFICIT
Preferred Stock ($0.0001 par value, 1,000,000 shares authorized, none issued and
outstanding at June 30, 2024 and December 31, 2023, respectively)
–
–
Common Stock ($0.0001 par value,100,000,000 shares authorized, 26,456,764 and 22,272,478
shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively)*
2,645
2,227
Additional paid-in capital
1,894,563
1,526,773
Accumulated deficit
(15,026,864)
(8,247,862)
Accumulated other comprehensive loss
(1,108)
(1,075)
Total Stockholders’ Deficit
(13,130,764)
(6,719,937)
Total Liabilities and Stockholders’ Deficit
$
13,251,207
$
14,200,421
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Six Months Ended
For the Six Months Ended
June 30,
June 30,
2024
2023
(Unaudited)
(Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
$
(4,075,125)
$
(973,949)
Adjustments to reconcile net income to net cash used in
operating activities:
Depreciation expense
79,720
83,388
Allowance for credit losses
24,391
789
Amortization of operating right-of-use asset
155,295
204,732
Amortization of debt issuance cost
–
73,782
Deferred taxes benefits
–
(242,908)
Loss on loan extinguishment
–
233,450
Loss on early termination of right-of-use asset
–
33,423
Stock compensation expenses
367,805
–
Non cash finance expense
1,000,000
–
Change in operating assets and liabilities:
Accounts receivable
(1,253,986)
(105,364)
Inventories
876,751
2,242,101
Prepayments and other current assets
(207,731)
89,676
Security deposit
20,000
49,960
Accounts payable
796,876
(1,775,240)
Other payables and accrued liabilities
485,314
(68,251)
Accrued interest payable – related parties
34,203
26,033
Operating lease liabilities
(103,284)
(260,484)
Tax accrual
112,097
12,597
Deferred income – Contract liabilities
(54,841)
(121,006)
Net cash used in operating activities
(1,742,515)
(497,271)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from the reverse recapitalization
1,120,177
–
Payments of transaction costs incurred by Lakeshore
(1,044,980)
–
Repayments of promissory note – related party of Lakeshore
(75,000)
–
Loan to related parties
–
(150,000)
Loan to Lakeshore
(40,000)
–
Loan repayment from third parties
–
132,913
Net cash used in investing activities
(39,803)
(17,087)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of deferred offering costs
(266,925)
(533,929)
Long-term loan borrowing
–
3,338,546
Repayments on long-term loan
(130,689)
(54,999)
Short-term loan borrowing from third parties
2,487,500
4,812
Repayments on short-term loan from third parties
(498,760)
(1,763,814)
Short-term loan borrowing from related parties
–
773,255
Repayments on short-term loan from related parties
–
(700,000)
Borrowings from other payables – related parties
–
1,000
Net cash provided by financing activities
1,591,126
1,064,871
EFFECT OF FOREIGN EXCHANGE ON CASH
(36)
792
CHANGES IN CASH
(191,228)
551,305
CASH AND CASH EQUIVALENT, beginning of period
221,760
810,371
CASH AND CASH EQUIVALENT, end of period
$
30,532
$
1,361,676
Source : Nature's Miracle Reports Second Quarter 2024 Financial Update
>
This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
